PET/CT scans in ovarian cancer: prognostic versus predictive utility?
The use of PET/CT has been advocated in the management of ovarian cancer as a diagnostic strategy to assist in patient management. To date, data in the peer reviewed literature support the argument that findings on PET/CT reveal evidence of the extent of disease and may be helpful in documenting disease recurrence. However, it remains to be determined through the conduct of phase 3 randomized trials if the information generated will be useful in predicting benefit of a management plan specifically selected based on the results of this expensive radiographic procedure.
Markman
M
M
Department of Gynecologic Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. mmarkman@mdanderson.org
D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D011379:Prognosis; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed